200 related articles for article (PubMed ID: 6107191)
1. Gastric inhibitory polypeptide.
Ebert R; Creutzfeldt W
Clin Gastroenterol; 1980 Sep; 9(3):679-98. PubMed ID: 6107191
[TBL] [Abstract][Full Text] [Related]
2. Disturbances of the entero-insular axis.
Creutzfeldt W; Ebert R; Nauck M; Stöckmann F
Scand J Gastroenterol Suppl; 1983; 82():111-9. PubMed ID: 6356314
[TBL] [Abstract][Full Text] [Related]
3. Secretory effects of gastric inhibitory polypeptide on the isolated perfused porcine pancreas.
Jensen SL; Holst JJ; Nielsen OV; Lauritsen KB
Acta Physiol Scand; 1981 Mar; 111(3):233-8. PubMed ID: 7032210
[TBL] [Abstract][Full Text] [Related]
4. Gastric inhibitory polypeptide (GIP).
Sarson DL
J Clin Pathol Suppl (Assoc Clin Pathol); 1978; 8():31-7. PubMed ID: 399609
[No Abstract] [Full Text] [Related]
5. Clinical studies with gastric inhibitory polypeptide.
Brown JC; Otte S
World J Surg; 1979 Sep; 3(5):553-8. PubMed ID: 516774
[TBL] [Abstract][Full Text] [Related]
6. The incretin concept today.
Creutzfeldt W
Diabetologia; 1979 Feb; 16(2):75-85. PubMed ID: 32119
[TBL] [Abstract][Full Text] [Related]
7. Interaction of fat-stimulated gastric inhibitory polypeptide on pancreatic alpha and beta cell function.
Verdonk CA; Rizza RA; Nelson RL; Go VL; Gerich JE; Service FJ
J Clin Invest; 1980 May; 65(5):1119-25. PubMed ID: 6988457
[TBL] [Abstract][Full Text] [Related]
8. [Gastric inhibitory polypeptide (GIP) (author's transl].
Ebert R; Finke U
Z Gastroenterol; 1978 May; 16(5):311-6. PubMed ID: 654387
[TBL] [Abstract][Full Text] [Related]
9. The enteric enhancement of glucose-stimulated insulin release. The role of GIP in aging, obesity, and non-insulin-dependent diabetes mellitus.
Elahi D; Andersen DK; Muller DC; Tobin JD; Brown JC; Andres R
Diabetes; 1984 Oct; 33(10):950-7. PubMed ID: 6383904
[TBL] [Abstract][Full Text] [Related]
10. Hypersecretion of gastric inhibitory polypeptide following oral glucose in diabetes mellitus.
Ross SA; Brown JC; Dupré J
Diabetes; 1977 Jun; 26(6):525-9. PubMed ID: 324834
[TBL] [Abstract][Full Text] [Related]
11. [Gastrointestinal hormones and related neuropeptides. IV. The secretion group: gastric inhibitory polypeptide (GIP), intestinal pancreatic glucagon-like immunoreactants (intestinal GLI) and PHI].
Krowicki Z; Sadowska-Krowicka H; Zych F
Postepy Hig Med Dosw; 1984; 38(4):513-34. PubMed ID: 6399110
[No Abstract] [Full Text] [Related]
12. Serum gastric inhibitory polypeptide (GIP) in duodenal ulcer disease: relationship to glucose tolerance, insulin, and gastrin release.
Arnold R; Creutzfeldt W; Ebert R; Becker HD; Börger HW; Schafmayer A
Scand J Gastroenterol; 1978; 13(1):41-7. PubMed ID: 635445
[TBL] [Abstract][Full Text] [Related]
13. GIP and the entero-insular axis.
Brown JC; Otte SC
Clin Endocrinol Metab; 1979 Jul; 8(2):365-77. PubMed ID: 383323
[No Abstract] [Full Text] [Related]
14. The evidence for the regulatory role of endogenous GIP as a glucose dependent insulinotropic hormone in patients with duodenal ulcer.
Takemura J; Seino Y; Yamamura T; Yoshiya K; Ishikawa Y; Itoh N; Imura H
Clin Endocrinol (Oxf); 1983 Sep; 19(3):345-53. PubMed ID: 6354520
[TBL] [Abstract][Full Text] [Related]
15. Glucose-dependent insulinotropic polypeptide: effects on insulin and glucagon secretion in humans.
Christensen MB
Dan Med J; 2016 Apr; 63(4):. PubMed ID: 27034187
[TBL] [Abstract][Full Text] [Related]
16. Gastric inhibitory polypeptide (GIP) and insulin release in the obese Zucker rat.
Chan CB; Pederson RA; Buchan AM; Tubesing KB; Brown JC
Diabetes; 1984 Jun; 33(6):536-42. PubMed ID: 6373459
[TBL] [Abstract][Full Text] [Related]
17. Oral glucose augmentation of insulin secretion. Interactions of gastric inhibitory polypeptide with ambient glucose and insulin levels.
Andersen DK; Elahi D; Brown JC; Tobin JD; Andres R
J Clin Invest; 1978 Jul; 62(1):152-61. PubMed ID: 659629
[TBL] [Abstract][Full Text] [Related]
18. Overview of incretin hormones.
Efendic S; Portwood N
Horm Metab Res; 2004; 36(11-12):742-6. PubMed ID: 15655702
[TBL] [Abstract][Full Text] [Related]
19. [Physiology and pathology of the entero-insular axis].
Creutzfeldt W
Schweiz Med Wochenschr; 1985 Jul; 115(29):970-3. PubMed ID: 3901250
[TBL] [Abstract][Full Text] [Related]
20. Clinical endocrinology and metabolism. Glucose-dependent insulinotropic polypeptide/gastric inhibitory polypeptide.
Meier JJ; Nauck MA
Best Pract Res Clin Endocrinol Metab; 2004 Dec; 18(4):587-606. PubMed ID: 15533777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
